Literature DB >> 12436940

The active role of dendrites in the regulation of magnocellular neurosecretory cell behavior.

Mike Ludwig1, Nancy Sabatier, Govindan Dayanithi, John A Russell, Gareth Leng.   

Abstract

The interactions of the dendritically released neuropeptides vasopressin and oxytocin with co-released neuroactive substances such as opioids and nitric oxide are reviewed. Endogenous opioids regulate magnocellular neurons at the level of the supraoptic nucleus and the relationship of dendritically released peptides and co-released opioids seems to be dependent on the stimulus given and the physiological state of the animal. Nitric oxide has a prominent inhibitory action on supraoptic neurons and these actions are predominantly mediated indirectly by GABA inputs. The role of these co-released neuroactive substances in differentially regulated release of neuropeptides from dendrites versus distant axon terminals has to be determined in more detail. A picture emerges in which release of vasopressin and oxytocin from different anatomical compartments of a single neuron may arise from different intracellular secretory pools and their preparation before release.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12436940     DOI: 10.1016/s0079-6123(02)39021-6

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  6 in total

1.  NMDA receptors trigger neurosecretion of 5-HT within dorsal raphe nucleus of the rat in the absence of action potential firing.

Authors:  C P J de Kock; L N Cornelisse; N Burnashev; J C Lodder; A J Timmerman; J J Couey; H D Mansvelder; A B Brussaard
Journal:  J Physiol       Date:  2006-10-19       Impact factor: 5.182

2.  Acute hypernatremia exerts an inhibitory oxytocinergic tone that is associated with anxiolytic mood in male rats.

Authors:  Charles J Frazier; Dipanwita Pati; Helmut Hiller; Dan Nguyen; Lei Wang; Justin A Smith; Kaley MacFadyen; Annette D de Kloet; Eric G Krause
Journal:  Endocrinology       Date:  2013-05-07       Impact factor: 4.736

3.  Colocalization of FM1-43, Bassoon, and GnRH-1: GnRH-1 release from cell bodies and their neuroprocesses.

Authors:  Lidia C Fuenzalida; Kim L Keen; Ei Terasawa
Journal:  Endocrinology       Date:  2011-09-06       Impact factor: 4.736

4.  Antagonism of mGlu2/3 receptors in the nucleus accumbens prevents oxytocin from reducing cued methamphetamine seeking in male and female rats.

Authors:  Aurelien Bernheim; Kah-Chung Leong; Carole Berini; Carmela M Reichel
Journal:  Pharmacol Biochem Behav       Date:  2017-09-01       Impact factor: 3.533

Review 5.  Somato-dendritic vasopressin and oxytocin secretion in endocrine and autonomic regulation.

Authors:  Colin H Brown; Mike Ludwig; Jeffrey G Tasker; Javier E Stern
Journal:  J Neuroendocrinol       Date:  2020-05-14       Impact factor: 3.870

Review 6.  Central oxytocin and food intake: focus on macronutrient-driven reward.

Authors:  Anica Klockars; Allen Stuart Levine; Pawel Karol Olszewski
Journal:  Front Endocrinol (Lausanne)       Date:  2015-04-28       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.